Vaccination Against Human Papillomavirus

CLINICAL QUESTION: Who should receive human papillomavirus (HPV) vaccination? BOTTOM LINE: Catch-up vaccination is now recommended for all persons through age 26 years. For persons aged 27 through 45 years, clinicians and patients should now jointly decide whether HPV vaccination is appropriate. Rou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of dermatology (1960) 2020-11, Vol.156 (11), p.1246-1247
Hauptverfasser:	Marks, Dustin H, Katz, Kenneth A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Adults Advisory Committees - standards Centers for Disease Control and Prevention, U.S. - standards Child Evidence-Based Medicine - standards Female Human papillomavirus Humans Immunization Immunization Schedule Male Mass Vaccination - standards Papillomavirus Infections - epidemiology Papillomavirus Infections - prevention & control Papillomavirus Infections - virology Papillomavirus Vaccines - administration & dosage Pediatrics Practice Guidelines as Topic Teenagers United States - epidemiology Vaccines Womens health Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	CLINICAL QUESTION: Who should receive human papillomavirus (HPV) vaccination? BOTTOM LINE: Catch-up vaccination is now recommended for all persons through age 26 years. For persons aged 27 through 45 years, clinicians and patients should now jointly decide whether HPV vaccination is appropriate. Routine HPV vaccination at age 11 or 12 years (or as early as age 9 years) continues to be recommended.
ISSN:	2168-6068 2168-6084
DOI:	10.1001/jamadermatol.2020.2927